在西洛利木斯治疗期间,形喷发可能由克拉里胺引发
Koki Kataoka1, Saeko Nakajima1,2, Takashi Nomura1,3
1Dermatology, Kyoto University Graduate School of Medicine, Kyoto, JPN.
Cureus
|June 26, 2024
概括
形喷发,西罗 (一种mTOR抑制剂) 的副作用,可能会因药物相互作用而加剧克拉里斯罗米. 这种相互作用可以提高西罗的水平,可能引发或恶化皮肤反应.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 众所周知,mTOR抑制剂西罗利木斯会引起形喷发.
- 这种副作用的确切机制和剂量依赖性尚未完全理解.
研究的目的:
- 报告一种可能与西罗和克拉里思罗米辛之间药物相互作用相关的形喷发病例.
- 探索细胞染色体P450 3A (CYP3A) 在与西罗相关的皮肤学副作用中的作用.
主要方法:
- 一个40岁的日本妇女接受全身西洛治疗的案例报告.
- 在 klarithromycin 给药后观察形喷发的发展.
- 在停止和重新服用西洛时监测喷发变化.
主要成果:
- 患者在开始服用克拉里思罗米辛同时服用西洛利木斯后出现了形喷发.
- 喷发在西洛利木斯停止后消失,并在恢复时复发.
- 这些发现表明西罗和通过CYP3A调解的澄胺之间存在潜在的相互作用,导致西罗水平升高.
结论:
- 药物相互作用,特别是涉及CYP3A抑制剂,如清素,可能会增加西罗血水平,并加速或加剧形喷发.
- 临床医生应考虑西罗素诱导的形喷发的可能性,特别是在同时开CYP3A抑制剂时.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
156
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156
Pulmonary Tuberculosis I
231
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
231
Drugs for Treatment of Ulcerative Colitis in IBD
134
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
134
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
115
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
115


